Amgen
AMGN
#99
Rank
NZ$308.41 B
Marketcap
NZ$572.75
Share price
-3.02%
Change (1 day)
25.91%
Change (1 year)

The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.

Amgen (AMGN) - Total assets

Total assets on the balance sheet as of September 2025 : NZ$156.50 Billion

According to Amgen's latest financial reports the company's total assets are NZ$156.50 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Amgen - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31NZ$162.84 B6%
2023-12-31NZ$153.62 B49.78%
2022-12-31NZ$102.56 B14.54%
2021-12-31NZ$89.54 B2.64%
2020-12-31NZ$87.24 B-1.59%
2019-12-31NZ$88.65 B-10.46%
2018-12-31NZ$99.01 B-12.05%
2017-12-31NZ$112.57 B0.46%
2016-12-31NZ$112.06 B7.35%
2015-12-31NZ$104.39 B18.53%
2014-12-31NZ$88.07 B9.46%
2013-12-31NZ$80.46 B21.91%
2012-12-31NZ$66.00 B5.41%
2011-12-31NZ$62.61 B11.09%
2010-12-31NZ$56.36 B3.31%
2009-12-31NZ$54.56 B-13.12%
2008-12-31NZ$62.79 B38.87%
2007-12-31NZ$45.22 B-5.71%
2006-12-31NZ$47.96 B11.89%
2005-12-31NZ$42.86 B4.67%
2004-12-31NZ$40.95 B1.94%
2003-12-31NZ$40.17 B-14.04%
2002-12-31NZ$46.72 B201.17%
2001-12-31NZ$15.51 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
NZ$362.39 B 131.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$168.21 B 7.49%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$143.16 B-8.52%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
NZ$101.62 B-35.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$50.70 B-67.60%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$232.46 B 48.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$334.76 B 113.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$10.72 B-93.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$199.54 B 27.51%๐Ÿ‡บ๐Ÿ‡ธ USA